tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bayer says FDA extends review period for elinzanetant NDA
PremiumThe FlyBayer says FDA extends review period for elinzanetant NDA
18d ago
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
26d ago
Bayer’s emodepside granted FDA orphan designation
Premium
The Fly
Bayer’s emodepside granted FDA orphan designation
26d ago
Bayer upgraded to Buy from Hold at HSBC
PremiumThe FlyBayer upgraded to Buy from Hold at HSBC
2M ago
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
Premium
The Fly
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
2M ago
Bayer upgraded to Buy from Neutral at Goldman Sachs
Premium
The Fly
Bayer upgraded to Buy from Neutral at Goldman Sachs
2M ago
OTC Markets Group welcomes Bayer to OTCQX
PremiumThe FlyOTC Markets Group welcomes Bayer to OTCQX
3M ago
Trump admin report implies companies are worsening health of children, FT says
Premium
The Fly
Trump admin report implies companies are worsening health of children, FT says
3M ago
Bayer reports FDA approved Jivi for use in pediatric patients 7 years and older
Premium
The Fly
Bayer reports FDA approved Jivi for use in pediatric patients 7 years and older
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100